Spironolactone and Breast Cancer: Fear Not!

@article{Heymann2020SpironolactoneAB,
  title={Spironolactone and Breast Cancer: Fear Not!},
  author={Warren R Heymann},
  journal={Journal of the American Academy of Dermatology},
  year={2020}
}
  • W. Heymann
  • Published 28 July 2020
  • Medicine
  • Journal of the American Academy of Dermatology

References

SHOWING 1-5 OF 5 REFERENCES

Treatment of acne with spironolactone: a retrospective review of 395 adult patients at Mayo Clinic, 2007–2017

Few large studies have assessed spironolactone treatment of adult female acne and the use of this drug in clinical practice is still unclear.

Safety of 5α-reductase inhibitors and spironolactone in breast cancer patients receiving endocrine therapies

Most patients did not show increased estrogen levels with spironolactone and there were no data suggesting increased risk of breast cancer, according to a review of published studies from January 1978 through April 2018.